Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Europe recommends approval for updated Pfizer-BioNTech and Moderna vaccines targeting new COVID variant.
The European Medicines Agency's committee has recommended approval for updated COVID-19 vaccines from Pfizer-BioNTech and Moderna targeting the LP.8.1 variant.
Both vaccines aim to prevent COVID-19 in individuals six months and older and are expected to be available for the 2025-2026 season if the European Commission approves.
The updated vaccines show improved immune responses against current variants.
Manufacturing has already begun, with shipments ready upon authorization.
21 Articles
Europa recomienda la aprobación para las vacunas actualizadas de Pfizer-BioNTech y Moderna dirigidas a la nueva variante de COVID.